About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
Biosimilars
Current news
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2021
22.12.2021
Updated Statement on supply of medicines to Northern Ireland
17.12.2021
Statement on Northern Ireland Protocol
26.11.2021
Medicines UK supply issues dashboard November 2021
02.11.2021
Medicines UK supply issues dashboard October 2021
21.10.2021
Updated statement on Northern Ireland Protocol and Supply of Medicines
15.09.2021
Medicines UK supply issues dashboard September 2021
16.08.2021
Medicines UK supply issues dashboard August 2021
22.07.2021
Statement on current supply situation to Northern Ireland
20.07.2021
Medicines UK supply issues dashboard July 2021
15.07.2021
Medicines UK Statement with regards to the CMA announcement of fines in relation to hydrocortisone tables
07.07.2021
Reaction to Office for Life Sciences Vision
21.06.2021
Medicines UK supply issues dashboard June 2021
21.05.2021
Medicines UK supply issues dashboard May 2021
20.04.2021
Medicines UK supply issues dashboard April 2021
19.04.2021
Medicines UK comments in response to the 19 April Financial Times piece on the interpretation of the Northern Ireland Protocol
25.03.2021
Reaction to the establishment of the UK Health Security Agency
16.03.2021
Batch testing announcement and review
18.02.2021
Medicines UK Appoints Mark Samuels as New CEO
Highlights
22.12.2021
Updated Statement on supply of medicines to Northern Ireland
17.12.2021
Statement on Northern Ireland Protocol
26.11.2021
Medicines UK supply issues dashboard November 2021
02.11.2021
Medicines UK supply issues dashboard October 2021
21.10.2021
Updated statement on Northern Ireland Protocol and Supply of Medicines
15.09.2021
Medicines UK supply issues dashboard September 2021
16.08.2021
Medicines UK supply issues dashboard August 2021
22.07.2021
Statement on current supply situation to Northern Ireland
20.07.2021
Medicines UK supply issues dashboard July 2021
15.07.2021
Medicines UK Statement with regards to the CMA announcement of fines in relation to hydrocortisone tables
07.07.2021
Reaction to Office for Life Sciences Vision
21.06.2021
Medicines UK supply issues dashboard June 2021
21.05.2021
Medicines UK supply issues dashboard May 2021